Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: August 4, 2021
Reporting Period: Second Quarter ended June 30, 2021
Business Context: The filing serves as a notification of the Company's financial results for the quarter ended June 30, 2021, and includes a business update. The Company is an emerging growth company incorporated in Nevada.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The provided Form 8-K text does not contain specific numerical values for revenue, net income, cash flow, operating margins, debt levels, or liquidity positions. These figures are referenced as being contained within the attached press release (Exhibit 99.1) but are not explicitly stated in the body of this filing.
Material Changes
Comparison to Prior Period: The filing text does not provide specific comparative data or material changes versus the prior comparable period. It only indicates that a press release detailing these results was issued on August 4, 2021.
Guidance, Outlook, and Other Events
- Management Commentary: The Company issued a press release on August 4, 2021, providing a business update alongside financial results.
- Upcoming Events: On August 5, 2021, the Company announced it will present at the BTIG Virtual Biotechnology Conference held from August 9 through August 10, 2021.
- Risks and Contingencies: No specific risks or contingencies are detailed in the text of this 8-K filing.
- Unusual Items: None reported in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 4, 2021) for specific Q2 2021 financial figures (revenue, cash position, net loss).
- Verify the Company's cash runway and burn rate as disclosed in the attached press release.
- Monitor the presentation at the BTIG Virtual Biotechnology Conference (August 9-10, 2021) for updated operational milestones or guidance.
- Confirm the status of the Company's emerging growth company election and any related accounting standard transitions.